Refine by MP, party, committee, province, or result type.

Results 1-9 of 9
Sorted by relevance | Sort by date: newest first / oldest first

Health committee  I completely agree with you. What you're saying is somewhat in line with the main principles of the low-threshold approach. It's about knowing who the population you want to serve is, where they are, what their needs are, and how you can reduce the barriers that prevent them fro

February 29th, 2024Committee meeting

Dr. Marie-Ève Goyer

Health committee  Yes, I can do that, of course.

February 29th, 2024Committee meeting

Dr. Marie-Ève Goyer

Health committee  I'll try to go back over the drug diversion cognitive equation so we can all agree on the diagnosis and treatment plan. The first thing I hear people say is that if you prescribe safe supply, there's necessarily going to be diversion. May I remind everyone that there are very fe

February 29th, 2024Committee meeting

Dr. Marie-Ève Goyer

Health committee  When it comes to tackling complex problems, such as addiction or pain, pharmacology of course has its place. Complex problems call for complex answers. This goes back to what we were saying earlier about the importance of having a complementary set of services and care to treat c

February 29th, 2024Committee meeting

Dr. Marie-Ève Goyer

Health committee  What I'm trying to say is that there won't be a single solution to such a complex and weighty problem, a crisis involving so many deaths. Many of us have talked about existing solutions that are not being sufficiently implemented. That seems to me to be the easiest part to solve,

February 29th, 2024Committee meeting

Dr. Marie-Ève Goyer

Health committee  You've asked me several questions. I'll try to answer them briefly. I think there are several false equations relative to safer supply. First, I want to reiterate that the use of this practice is currently minimal. Few doctors use it, and few patients receive such a service. If

February 29th, 2024Committee meeting

Dr. Marie-Ève Goyer

Health committee  If we really want to have an adequate public health response to the data circulating all over the place, we have to agree on the problem. I have a very good understanding of the history of overprescription in Canada and North America. Ms. Hyshka has just illustrated it very clear

February 29th, 2024Committee meeting

Dr. Marie-Ève Goyer

Health committee  Thank you for the question. As I said, we need to make this a priority and build a bit on the models we use to treat chronic diseases. Opioid dependence is obviously much more complex, but the models for organizing services and training professionals to treat chronic diseases, s

February 29th, 2024Committee meeting

Dr. Marie-Ève Goyer

Health committee  Good morning. I'll be doing my introduction in English, but my talk in French. I'm happy to take questions in English or French—whatever works best. First, thank you for having me here. I also thank you in the name of my patients, who are dying very regularly. I'm happy to se

February 29th, 2024Committee meeting

Dr. Marie-Ève Goyer